Used in pharmaceutical research as an intermediate in the synthesis of biologically active compounds, particularly those targeting central nervous system disorders. Its structure supports the development of novel agents with potential applications in treating neurological and psychiatric conditions. The compound's pyrrolidine and pyridine moieties contribute to its utility in medicinal chemistry for optimizing drug-like properties such as solubility, bioavailability, and target binding affinity.